[
    "{\"step_by_step_thinking\": \"Based on the information provided in the relevant documents, it is stated in Document [0] that tumoral somatostatin receptor subtype 2a (sst2a) immunohistochemistry (IHC) has no additional value compared to somatostatin receptor scintigraphy (SRS) uptake using OctreoScan\u00ae in predicting tumor response after peptide receptor radiotherapy. Therefore, the answer is B. no.\", \"answer_choice\": \"B\"}"
]